Millie
your market intelligence analyst
Search Results
Edit Save
643 results
Vascular News 08/16/2019 10:15
The BASIL-3 study, which was halted in response to findings reported in the Journal of the American Heart Association (JAHA) that paclitaxel-coated and –eluting devices were associated with an increased mortality signal when used in the femoropopliteal arteries, is on course to resume in September 2019.
Vascular News 08/16/2019 09:48
International Cardio Corporation (ICC) announced that it has achieved the first human use of its high-intensity focused ultrasound (HIFU) system to designed to treat peripheral vascular disease (PVD). The Minneapolis-based company said its HIFU Synthesiser system is undergoing a 15-patient safety study in The Netherlands to investigate its feasibility and safety for the treatment of […]. .
Vascular News 08/16/2019 05:44
Ascyrus Medical announced today that it has received Breakthrough Device Designation from the US Food and Drug Administration (FDA) for its Ascyrus Medical Dissection Stent (AMDS) to treat acute Type A aortic dissections. This designation underlines the clinical importance of the AMDS and continues the advancement of the technology globally. Ascyrus Medical conducted the largest […]. .
Vascular News 08/14/2019 10:14
A private equity firm, Palatine (Manchester, UK), has announced that it has made a “significant investment” into a UK centre—Veincentre—that provides endovenous laser ablation (EVLA) for the management of varicose veins. The investment, according to Palatine, is the fourth to be made from the firm’s £100m “Impact Fund” that “targets companies with a social and/or […]. .
Vascular News 08/14/2019 06:11
 Ian Loftus (London, UK), president of the Vascular Society for Great Britain and Ireland, tells BLearning about the most recent developments in the UK’s NICE guidance on abdominal aortic aneurysm. The draft version of the guideline created a furore, when released for consultation in 2018, with its recommendation that patients with an unruptured aneurysm […]. .
Vascular News 08/09/2019 06:00
Endologix has announced the investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) to commence a new pivotal study to evaluate the safety and effectiveness of the Nellix Chimney EndoVascular Aneurysm Sealing System (chEVAS) for the endovascular treatment of complex abdominal aortic aneurysms (AAA).
Vascular News 08/08/2019 07:24
Medtronic has issued the following statement regarding the US Food and Drug Administration’s (FDA) updated letter to healthcare providers for paclitaxel-devices in patients with peripheral artery disease (PAD) in the superficial femoropopliteal artery (SFA): "Medtronic would like to thank FDA and the panel members for their thoughtful deliberations and dedication to providing physicians, patients, and [...]. .
Vascular News 08/07/2019 05:41
The US Food and Drug Administration (FDA) have denied BD premarket approval (PMA) for the company’s Lutonix drug-coated balloon (DCB) in the treatment of peripheral arterial disease (PAD). Speaking in the company’s third quarter conference call on 6 August, BD CEO Vincent Forlenza told analysts: “Regarding our FDA, PMA submission for Lutonix below the knee […]. The post FDA notifies BD that Lutonix paclitaxel balloon PMA request for below the knee “not approvable in current form” appeared first on Vascular News.
Vascular News 08/07/2019 05:34
 Giovanni Torsello (Münster, Germany) and Mauro Gargiulo (Bologna, Italy) discuss the “very high” morbidity and mortality caused by open surgery when treating complex aortic aneurysms. This is why, they say, the use of fenestrated and branched grafts is a valuable alternative treatment. Torsello talks about the complications often found with many bridging stents due […]. The post CX 2019: VBX set to be a “game-changer” for treating complex aortic aneurysms appeared first on Vascular News.
Vascular News 08/06/2019 09:48
Members of the International Working Group on the Diabetic Foot (IWGDF) presented up-to-date guidelines for the diagnosis, prognosis and treatment of diabetic foot ulcers at the 29th conference of the European Wound Management Association (EWMA; 5–7 June, Gothenburg, Sweden), highlighting development on the areas of infection and peripheral arterial disease (PAD).
Vascular News 08/05/2019 04:50
Bentley has announced the company celebrated its tenth anniversary on June, 29th 2019. The announcement states that the story of the company is a story of remarkable global expansion driven by a dedicated workforce and an innovative product base that has seen core endovascular staples, like the widely-used BeGraft peripheral stent, sit alongside niche products, […]. The post Bentley celebrates employee contribution on its 10th anniversary appeared first on Vascular News.
Vascular News 08/02/2019 08:43
Two-year results from the MOBILE (Marrowstim treatment of limb ischaemia in patients with severe peripheral arterial disease) trial indicate that injecting concentrated bone marrow aspirate (cBMA, Zimmer Biomet), vs. placebo, into patients with critical limb ischaemia is associated with a significant increase in amputation-free survival at two years.
Vascular News 08/02/2019 06:04
Jos van den Berg (Lugano, Switzerland), Antonio Micari (Bergamo, Italy) and Marianne Brodmann (Graz, Austria) sit down after a specially convened US FDA panel reviewed paclitaxel device data, with recommendations still to come. The physicians discuss the safety of paclitaxel devices and examine what the evidence says. Micari presented a patient-level analysis from the IN.PACT […]. The post Webinar: Safety of paclitaxel devices – what does the evidence say? appeared first on Vascular News.
Vascular News 07/31/2019 08:58
The National Institute for Health and Care Excellence (NICE) in the UK has published a positive draft final appraisal determination recommending the use of rivaroxaban (brand name Xarelto, Bayer) by the National Health Service (NHS) in England. The NICE recommendation sets out a dose of 2.5mg twice daily, combined with 75–100mg aspirin once daily, as […]. The post Rivaroxaban recommended by NICE for peripheral and coronary artery disease patients appeared first on Vascular News.

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications